Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPennon Regulatory News (PNN)

Share Price Information for Pennon (PNN)

Share Price is delayed by 15 minutes
Get Live Data
513.00    9.50 (1.89%)
Bid:
509.00
Ask:
509.50
Spread: 0.50 (0.098%)
Market Cap: £2.42b
PNN Live PriceLast checked at - London Stock Exchange

Intraday Pennon Share Chart

Trading Statement

31 Mar 2025 07:00

RNS Number : 8625C
Pennon Group PLC
31 March 2025
 

PENNON GROUP PLC

31 March 2025

 

Trading Statement

Pennon Group announces the following trading update for the year ending 31 March 2025 ahead of announcing the full year results on 3 June 2025.

Key highlights

· Financial performance for the full year 2024/25 remains in line with management expectations

As anticipated,

§ EBITDA broadly flat H1 to H2 2024/25, with lower customer demand and inflationary cost pressures, offset by our reshaping and restructuring programme

§ Capital expenditure comparable with the H1 2024/25 run rate, reflects transitional expenditure and finalisation of K7.

· Non-underlying costs for our reshaping and transformation programmes and the finalisation of costs relating to the Brixham water supply incident of c.£36m.

· Continuing to deliver against our four priorities:

Over £1bn of investment programmes for K8 (2025-2030) underway

Strong water resources position at over 90% with industry leading water quality expected

One of only five companies in the industry to reduce storm overflow releases year on year, with bathing beach releases during the bathing season down by 21% since 2020

Targeted to retain EPA[1] 2* status for 2024/25

New package of c.£200m customer affordability support unlocked from 2025/26.

· Following announced acceptance of Ofwat's Final Determination for South West Water and Sutton and East Surrey Water, well placed for funding record investment programme having raised c.£1.3bn in 2024/25 via rights issue, public bonds, private placements and other opportunities.

For further information, please contact:

 

Pennon Group plc

+44(0)1392 443 260

Laura Flowerdew

Group Chief Financial Officer

 

Louise Rowe

Investor Relations

 

Media Enquiries

+44(0)207 251 3801

James Murgatroyd

FGS Global

 

Harry Worthington

 

 

 

Cautionary statement in respect of forward-looking statements 

Certain statements in this announcement are forward-looking statements relating to the Group's operations, performance and financial position based on current expectations of, and assumptions and forecasts made by, management. They are subject to a number of risks, uncertainties and other factors that could cause actual results, performance, or achievements of the Group to differ materially from any outcomes or results expressed or implied by such forward-looking statements.

The Group's principal risks were described in the 2024 Pennon Group Annual Report which can be viewed online at http://annualreport.pennon-group.co.uk. Such forward looking statements should therefore be construed in light of such risks, uncertainties and other factors and undue reliance should not be placed on them. They are made only as of the date of this announcement and no representation, assurance, guarantee, or warranty is given in relation to them including as to their accuracy, completeness, or the basis on which they are made.

No obligation is accepted to publicly revise or update these forward-looking statements or adjust them as a result of new information or for future events or developments, except to the extent legally required. Nothing in this Statement should be construed as a profit forecast.


[1] Environmental Performance Assessment (EPA) as measured and reported on an annual basis by the Environment Agency

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSDFESSEISEDD
Date   Source Headline
1st Jun 20267:00 amRNSTotal Voting Rights
29th May 20262:06 pmRNSHolding(s) in Company
20th May 20261:48 pmRNSDirector/PDMR Shareholding
14th May 202612:03 pmRNSDirector/PDMR Shareholding
6th May 20262:12 pmRNSAdmission to Trading
1st May 20264:31 pmRNSHolding(s) in Company
1st May 20267:00 amRNSTotal Voting Rights
30th Apr 20263:11 pmRNSHolding(s) in Company
27th Apr 20264:34 pmRNSHolding(s) in Company
24th Apr 20263:29 pmRNSHolding(s) in Company
22nd Apr 20264:30 pmRNSHolding(s) in Company
21st Apr 20261:17 pmRNSDirector/PDMR Shareholding
20th Apr 20264:09 pmRNSHolding(s) in Company
14th Apr 20264:24 pmRNSRescheduled Full-Year Results Date
1st Apr 20267:00 amRNSTotal Voting Rights
20th Mar 20262:06 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNSTrading Statement
2nd Mar 20267:00 amRNSTotal Voting Rights
23rd Feb 202612:58 pmRNSDirector/PDMR Shareholding
10th Feb 20267:00 amRNSConfirmation of Chief Executive Officer Start Date
5th Feb 202610:58 amRNSHolding(s) in Company
2nd Feb 20267:01 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSBlock listing Interim Review
23rd Jan 20263:21 pmRNSDirector/PDMR Shareholding
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
23rd Dec 20253:29 pmRNSDirector/PDMR Shareholding
23rd Dec 20253:29 pmRNSDirector/PDMR Shareholding
11th Dec 20251:16 pmRNSConfirmed Financial Calendar
9th Dec 20254:01 pmRNSDirector/PDMR Shareholding
9th Dec 20257:00 amRNSPennon Group CEO Transition Arrangements
1st Dec 20253:42 pmRNSEMTN: Publication of Supplementary Prospectus
1st Dec 20257:00 amRNSTotal Voting Rights
27th Nov 20257:00 amRNSHalf Year Results 2025/26
21st Nov 20254:24 pmRNSDirector/PDMR Shareholding
3rd Nov 20257:00 amRNSTotal Voting Rights
22nd Oct 20251:26 pmRNSDirector/PDMR Shareholding
7th Oct 20257:00 amRNSPennon appoints new Non-Executive Director
3rd Oct 20252:19 pmRNSDirector/PDMR Shareholding
2nd Oct 20257:00 amRNSPennon Group appoints Keith Haslett as new CEO
1st Oct 20257:00 amRNSTotal Voting Rights
26th Sep 20257:00 amRNSTrading Statement
23rd Sep 20254:16 pmRNSDirector/PDMR Shareholding
11th Sep 202512:09 pmRNSEMTN Programme: Publication of Final Terms
1st Sep 20257:00 amRNSTotal Voting Rights
28th Aug 20252:44 pmRNSDirector/PDMR Shareholding
22nd Aug 20259:41 amRNSEMTN Programme: Publication of Base Prospectus
20th Aug 20254:15 pmRNSDirector/PDMR Shareholding
1st Aug 20257:01 amRNSTotal Voting Rights
1st Aug 20257:00 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.